{"nct_id":"NCT02108964","title":"A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2014-06-06","start_date_type":"ACTUAL","primary_completion_date":"2018-03-22","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-15","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}